Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Symbotic Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B), while Symbotic Inc trades at $42.64 (market cap $5.46B). The key difference: Symbotic Inc is far larger — about 3.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Symbotic Inc for 23 Days on average.
| NUVB | SYM | |
|---|---|---|
Market Cap | $1.74B | $5.46B |
Volume | 9,289,619 | 1,965,805 |
Sector | Health | Industrials |
52-Week High | $9.54 | $87.30 |
52-Week Low | $3.41 | $38.22 |
Typical Hold Time | 1 Days | 23 Days |
Enterprise Value | $1.33B | $3.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SYM trades at $42.63, down 1.57% today, with bearish technical signals dominating (15 sell vs 2 buy indicators). The stock shows mixed fundamentals with strong revenue growth projected ($2.6B in 2026) but negative 2025 net income of -$16.94M and thin 0.31% net margin. Recent earnings show two misses against expectations, though Q4 2025 beat estimates. Analyst consensus remains bullish with $60.33 price target despite technical weakness.
SYM presents a growth story with $22.5B backlog and expanding AI/robotics market positioning, but faces execution risks from customer concentration (85% Walmart revenue) and profitability challenges. The stock trades at premium valuations (P/E 1,051.5, EV/EBITDA 74.05) requiring significant future earnings growth to justify. Near-term support at $40-42 levels critical for maintaining current pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
